Annals of Oncology

1

Heating the patient: a promising approach?

van der Zee, J.

Journal:

Annals of Oncology

Year:

2002

Language:

english

File:

PDF, 2.74 MB

english, 2002

2

Optimization of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of leucovorin, 5-FU and cisplatin (LV5FU2-P regimen) in patients with biliary tract carcinoma

Taieb, J., Mitry, E., Boige, V., Artru, P., Ezenfis, J., Lecomte, T., Clavero-Fabri, M. C., Vaillant, J. N., Rougier, P., Ducreux, M.

Journal:

Annals of Oncology

Year:

2002

Language:

english

File:

PDF, 82 KB

english, 2002

3

An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study

Mead, G. M., Sydes, M. R., Walewski, J., Grigg, A., Hatton, C. S., Norbert, P., Guarnaccia, C., Lewis, M. S., McKendrick, J., Stenning, S. P., Wright, D.

Journal:

Annals of Oncology

Year:

2002

Language:

english

File:

PDF, 207 KB

english, 2002

4

Primary cutaneous non-Hodgkin's lymphoma with aggressive histology: inferior outcome is associated with peripheral T-cell type and elevated lactate dehydrogenase, but not extent of cutaneous involvement

Visco, C., Medeiros, L. J., Jones, D., Smith, T., Rodriguez, M. A., McLaughlin, P., Romaguera, J., Cabanillas, F., Sarris, A. H.

Journal:

Annals of Oncology

Year:

2002

Language:

english

File:

PDF, 198 KB

english, 2002

5

Reply to "Adjuvant interferon for melanoma", by K. Wheatley & N. Ives

Punt, C. J. A., Eggermont, A. M. M.

Journal:

Annals of Oncology

Year:

2002

Language:

english

File:

PDF, 22 KB

english, 2002

6

Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients

Ferrandina, G., Lauriola, L., Zannoni, G. F., Fagotti, A., Fanfani, F., Legge, F., Maggiano, N., Gessi, M., Mancuso, S., Ranelletti, F. O., Scambia, G.

Journal:

Annals of Oncology

Year:

2002

Language:

english

File:

PDF, 778 KB

english, 2002

7

Planning palliative or terminal care: the dilemma of doctors' prognoses in terminally ill cancer patients

Tanneberger, S., Malavasi, I., Mariano, P., Pannuti, F., Strocchi, E.

Journal:

Annals of Oncology

Year:

2002

Language:

english

File:

PDF, 37 KB

english, 2002

8

Combination gemcitabine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: report of a phase II study

Ngan, R. K. C., Yiu, H. H. Y., Lau, W. H., Yau, S., Cheung, F. Y., Chan, T. M., Kwok, C. H., Chiu, C. Y., Au, S. K., Foo, W., Law, C. K., Tse, K. C.

Journal:

Annals of Oncology

Year:

2002

Language:

english

File:

PDF, 98 KB

english, 2002

9

Relationship between objective responses in phase I trials and potential efficacy of non-specific cytotoxic investigational new drugs

Sekine, I., Yamamoto, N., Kunitoh, H., Ohe, Y., Tamura, T., Kodama, T., Saijo, N.

Journal:

Annals of Oncology

Year:

2002

Language:

english

File:

PDF, 73 KB

english, 2002

10

Exacerbation of oxaliplatin neurosensory toxicity following surgery

Gornet, J.-M., Savier, E., Lokiec, F., Cvitkovic, E., Misset, J. -L., Goldwasser, F.

Journal:

Annals of Oncology

Year:

2002

Language:

english

File:

PDF, 111 KB

english, 2002

11

Assessment of the risk/benefit ratio of phase II cancer clinical trials by Institutional Review Board (IRB) members

van Luijn, H. E. M., Musschenga, A. W., Keus, R. B., Robinson, W. M., Aaronson, N. K.

Journal:

Annals of Oncology

Year:

2002

Language:

english

File:

PDF, 93 KB

english, 2002

12

Whole-body hyperthermia (41.8 C) combined with bimonthly oxaliplatin, high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer: a phase II study

Hegewisch-Becker, S., Gruber, Y., Corovic, A., Pichlmeier, U., Atanackovic, D., Nierhaus, A., Hossfeld, D. K.

Journal:

Annals of Oncology

Year:

2002

Language:

english

File:

PDF, 107 KB

english, 2002

13

Bendamustine is effective in relapsed or refractory aggressive non-Hodgkin's lymphoma

Weidmann, E., Kim, S.-Z., Rost, A., Schuppert, H., Seipelt, G., Hoelzer, D., Mitrou, P. S.

Journal:

Annals of Oncology

Year:

2002

Language:

english

File:

PDF, 68 KB

english, 2002

14

Cyclooxygenase-2 (COX-2) a new prognostic and predictive factor for ovarian cancer? Are all the criteria fulfilled?

Nasi, M. L., Castiglione, M.

Journal:

Annals of Oncology

Year:

2002

Language:

english

File:

PDF, 45 KB

english, 2002

15

Advanced pancreatic cancer--5 years on

Rao, S., Cunningham, D.

Journal:

Annals of Oncology

Year:

2002

Language:

english

File:

PDF, 55 KB

english, 2002

16

Concomitant chemoradiation versus neoadjuvant chemotherapy in locally advanced cervical carcinoma: results from two consecutive phase II studies

Duenas-Gonzalez, A., Lopez-Graniel, C., Gonzalez-Enciso, A., Mohar, A., Rivera, L., Mota, A., Guadarrama, R., Chanona, G., de la Garza, J.

Journal:

Annals of Oncology

Year:

2002

Language:

english

File:

PDF, 108 KB

english, 2002

17

Neovastat (Ae-941) in refractory renal cell carcinoma patients: report of a phase II trial with two dose levels

Batist, G., Patenaude, F., Champagne, P., Croteau, D., Levinton, C., Hariton, C., Escudier, B., Dupont, E.

Journal:

Annals of Oncology

Year:

2002

Language:

english

File:

PDF, 87 KB

english, 2002

18

A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma

Ducreux, M., Rougier, P., Pignon, J.-P., Douillard, J.-Y., Seitz, J.-F., Bugat, R., Bosset, J.-F., Merouche, Y., Raoul, J.-L., Ychou, M., Adenis, A., Berthault-Cvitkovic, F., Luboinski, M.

Journal:

Annals of Oncology

Year:

2002

Language:

english

File:

PDF, 108 KB

english, 2002

19

B.A. Chabner, D.L. Longo (eds.) Cancer Chemotherapy and Biotherapy: Principles and Practice

de Vries, E. G. E., Willemse, P. H. B.

Journal:

Annals of Oncology

Year:

2002

Language:

english

File:

PDF, 28 KB

english, 2002

20

Back to baked potato? Or is it another "laboratory finding"?

Journal:

Annals of Oncology

Year:

2002

Language:

english

File:

PDF, 37 KB

english, 2002

21

Management of women with ductal carcinoma in situ of the breast: a population-based study

Verkooijen, H. M., Fioretta, G., de Wolf, C., Vlastos, G., Kurtz, J., Borisch, B., Schafer, P., Spiliopoulos, A., Sappino, A. P., Renella, R., Pittet, B., Schmid de Gruneck, J., Wespi, Y., Neyroud-Cas

Journal:

Annals of Oncology

Year:

2002

Language:

english

File:

PDF, 115 KB

english, 2002

22

Age-related differences among patients with follicular lymphoma and the importance of prognostic scoring systems: analysis from a population-based non-Hodgkin's lymphoma registry

Maartense, E., le Cessie, S., Kluin-Nelemans, H. C., Kluin, P. M., Snijder, S., Wijermans, P. W., Noordijk, E. M.

Journal:

Annals of Oncology

Year:

2002

Language:

english

File:

PDF, 181 KB

english, 2002

23

Reply: Prediction of survival in terminally ill cancer patients: why we cannot avoid an evidence-based palliative medicine

Tassinari, D., Maltoni, M., Amadori, D.

Journal:

Annals of Oncology

Year:

2002

Language:

english

File:

PDF, 34 KB

english, 2002

24

Adjuvant interferon for melanoma

Wheatley, K., Ives, N.

Journal:

Annals of Oncology

Year:

2002

Language:

english

File:

PDF, 53 KB

english, 2002

25

Volume 13; Issue 8

Heating the patient: a promising approach?

Optimization of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of leucovorin, 5-FU and cisplatin (LV5FU2-P regimen) in patients with biliary tract carcinoma

An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study

Primary cutaneous non-Hodgkin's lymphoma with aggressive histology: inferior outcome is associated with peripheral T-cell type and elevated lactate dehydrogenase, but not extent of cutaneous involvement

Reply to "Adjuvant interferon for melanoma", by K. Wheatley & N. Ives

Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients

Planning palliative or terminal care: the dilemma of doctors' prognoses in terminally ill cancer patients

Combination gemcitabine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: report of a phase II study

Relationship between objective responses in phase I trials and potential efficacy of non-specific cytotoxic investigational new drugs

Exacerbation of oxaliplatin neurosensory toxicity following surgery

Assessment of the risk/benefit ratio of phase II cancer clinical trials by Institutional Review Board (IRB) members

Whole-body hyperthermia (41.8 C) combined with bimonthly oxaliplatin, high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer: a phase II study

Bendamustine is effective in relapsed or refractory aggressive non-Hodgkin's lymphoma

Cyclooxygenase-2 (COX-2) a new prognostic and predictive factor for ovarian cancer? Are all the criteria fulfilled?

Advanced pancreatic cancer--5 years on

Concomitant chemoradiation versus neoadjuvant chemotherapy in locally advanced cervical carcinoma: results from two consecutive phase II studies

Neovastat (Ae-941) in refractory renal cell carcinoma patients: report of a phase II trial with two dose levels

A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma

B.A. Chabner, D.L. Longo (eds.) Cancer Chemotherapy and Biotherapy: Principles and Practice

Back to baked potato? Or is it another "laboratory finding"?

Management of women with ductal carcinoma in situ of the breast: a population-based study

Age-related differences among patients with follicular lymphoma and the importance of prognostic scoring systems: analysis from a population-based non-Hodgkin's lymphoma registry

Reply: Prediction of survival in terminally ill cancer patients: why we cannot avoid an evidence-based palliative medicine

Adjuvant interferon for melanoma

Table of Contents